News
Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five ...
5h
The Hearty Soul on MSNNew RSV Vaccine Targets Pregnant Women and Seniors in UK RolloutThe Iranian Foreign Minister Abbas Araghchi has condemned US strikes on the country’s nuclear facilities. He said Iran ...
A prominent paediatrician on Sunday urged people to take more precautions against a common virus known as RSV, saying cases ...
GSK plc has announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted the company's regulatory ...
A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used ...
12d
Zacks.com on MSNMerck Secures FDA Nod for New RSV Antibody Enflonsia in InfantsMRK wins early FDA approval for RSV antibody Enflonsia in infants, with U.S. launch planned before the 2025-26 season.
The FDA has approved clesrovimab, marketed as Enflonsia, for the prevention of RSV lower respiratory tract disease in ...
The U.S. Food and Drug Administration expanded its approval of Moderna's respiratory syncytial virus (RSV) vaccine on ...
6d
India Today on MSNWhy RSV prevention for infants is still years away in IndiaRespiratory Syncytial Virus is a growing health concern for Indian infants. Efforts for maternal RSV vaccine faces challenges ...
A scientist in charge of Covid-19 and respiratory syncytial virus data has abruptly resigned, telling colleagues she doesn’t ...
9d
GlobalData on MSNModerna’s mRNA RSV vaccine wins expanded FDA approval for younger adultsThe label expansion for Moderna’s jab arrives at a juncture in America’s changing vaccine regulatory landscape.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results